EarningsQ2 2025 Earnings Report

Alnylam Pharma (DUL) Q2 2025 Earnings Report

0 Followers

CH:DUL Q2 2025 EPS Results

Actual EPS-CHF0.42

Consensus EPS-CHF0.45

Beat/MissBeat by +CHF0.03

One Year Ago EPS-CHF0.11

Actual RevenueCHF642.32M

Expected RevenueCHF550.32M

Beat/MissBeat by +CHF92.00M

YoY Revenue Growth+17.26%

QuarterQ2 2025

Date07/31/2025

TimeBefore Open

Conference CallThursday, July 31, 2025

CH:DUL Upcoming Earnings

Alnylam Pharma's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

CH:DUL Q2 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	1.46 / -	1.528	―
Jul 30, 2026	2026 (Q2)	1.35 / 1.00	-0.423	337.25% (+1.43)
Apr 30, 2026	2026 (Q1)	0.72 / 1.25	-0.365	443.18% (+1.62)
Feb 12, 2026	2025 (Q4)	0.95 / 0.68	-0.54	226.15% (+1.22)
Oct 30, 2025	2025 (Q3)	0.47 / 1.53	-0.722	311.49% (+2.25)
Jul 31, 2025	2025 (Q2)	-0.45 / -0.42	-0.108	-292.31% (-0.32)
May 01, 2025	2025 (Q1)	-0.74 / -0.37	-0.432	15.38% (+0.07)
Feb 13, 2025	2024 (Q4)	-0.49 / -0.54	-0.913	40.91% (+0.37)
Oct 31, 2024	2024 (Q3)	-0.76 / -0.72	0.955	-175.65% (-1.68)
Aug 01, 2024	2024 (Q2)	-0.89 / -0.11	-1.835	94.12% (+1.73)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed